ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Inosan Biopharma Logo

Inosan Biopharma

At Inosan Biopharma we develop and distribute the latest generation antivenoms that meet highest manufacturing standars. Inosan is a biotechnology company that has integrated innovation and internal development of knowledge and technology to manufacture medicines for vulnerable patients' emergencies. Not all products and/or indications are available in all territories. Is a polyvalent equine antivenom specifically indicated for the treatment of Sub- Middle East and North African snake bites. Is a polyvalent equine antivenom specifically indicated for the treatment of Sub-Saharan African snake bites. Is a polyvalent equine antivenom specifically indicated for the treatment of Middle East and North African scorpion stings. It is a biological therapy indicated for the treatment of poisoning by bites or stings of venomous or poisonous animals; for example, snakes, scorpions and spiders whose function is to counteract the effects of a venom or at least prevent the undesirable damage of the toxic compounds. Serum, purified biological product of moderate efficacy and safety.

Quick overview

Mexico City, Mexico

Founded in 2012

51-100 Employees

Medium-Sized

Additional information

Working industry

Pharmaceuticals

Type of company

Manufacturer

Ownership structure

Privately Held

Locations

2 Locations

Number of products

1 Product

Specialised areas

Pharmaceuticals, Immonuglobulins, Antivenoms

Products & services of Inosan Biopharma

Inosan Biopharma offers a wide range of products and services

Product: PRODUCTS

Product

PRODUCTS

Go to product >

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

Mexico


Overall risk estimation:

High


ESG country scores

The ESG Data of countries are based on public sources

Environment

D

Grade (A-E)

View details

Social

C

Grade (A-E)

View details

Governance

D

Grade (A-E)

View details

Headquarter of Inosan Biopharma

Inosan Biopharma operates in 2 countries around the world

City: Mexico City

State: Mexico City

Country: Mexico

Locations of Inosan Biopharma

Get an overview of the locations of Inosan Biopharma

Location

Country

State

City

Headquarter

Mexico

Mexico City

Mexico City

Arbea Campus Empresarial

Spain

Community of Madrid

Alcobendas

Frequently asked questions (FAQ) about Inosan Biopharma

Some frequent questions that have been asked about Inosan Biopharma

The company headquarter of Inosan Biopharma is located in Mexico City, Mexico City, Mexico. Inosan Biopharma has subsidiaries in Spain

As of the latest available information Inosan Biopharma has around 51-100 employees worldwide.

Inosan Biopharma was founded in 2012

The company Inosan Biopharma has it's main focus in the industries of Pharmaceuticals

Based on the founding year and the amount of employees the company Inosan Biopharma seems to be a Medium-Sized at the current state. Note that over time that status can change

Competitors of Inosan Biopharma

Check out some interesting alternative companies to Inosan Biopharma

ToxiVen's Logo

ToxiVen

Coimbatore, India

11-50 Employees

2019

Since ToxiVen realises the therapeutic and scientific value of a broad spectrum of toxins present in vertebrate & invertebrate venoms and poisons, in partnership with Venomtech Limited (UK), we offer arrays (from over 200 species of snakes, spiders, scorpions, millipedes and lizards) of venoms and poisons, and their fractions for novel drug discovery which has an established success rate of over 98% to leading academic institutions and pharmaceutical industries. In ToxiVen’s point of view, venoms are a ‘Bio-Treasure’. Therefore, we provide a range of venoms, venom products and venom antibodies for basic scientific and clinical research. We are committed to bring world class whole venoms, venom components, venom antibodies, venom arrays and general antibodies in to the market for the effective treatment of snakebite, and also drug discovery. Together with a team of world-leading experts, ToxiVen tackles the complications of snakebite envenoming via developing diagnostic tools and next generation therapeutics.

VenomAid Diagnostics's Logo

VenomAid Diagnostics

Kongens Lyngby, Denmark

1-10 Employees

2018

At VenomAid we are on a mission to enable best-in-class snakebite care and reduce the global burden of snakebites. VenomAid is a medtech company at the forefront of revolutionizing snakebite care on a global scale by pioneering affordable diagnostics to reach previously neglected populations. VENOMAID EXTENDS ITS SEED ROUND TO A TOTAL OF $ 1.8 M FOR AFFORDABLE AND RAPID SNAKEBITE DIAGNOSTICS. Here, we had all been drawn to the Lab due to its overarching mission; to combat one of the world’s most neglected diseases - Snakebite - by introducing newer biotechnological methods into antivenom development, substituting a 125-year old method. By combining state-of-the-art antibody discovery, venomics insights, and affordable diagnostic technologies, we are developing the necessary tools to empower clinicians dealing with snakebite. By developing affordable technologies that can support clinical decision-making, we're committed to making snakebite care more accessible, efficient, and life-saving. Empowerment lies at the heart of our mission. Disposable materials for the course will be delivered at your high school.

SMARTOX's Logo

SMARTOX

Saint-Égrève, France

11-50 Employees

-

Smartox Biotechnology is a French research and manufacturing company specialized on animal venoms and toxins. Animal venom is a mixture of hundreds of compounds including proteins, peptide toxins and chemicals. Smartox Biotechnology offers a range of products and services dedicated to the life-sciences community based on the wealth of animal venoms.

CAMPINGCARAVANING PLAYA DE ARIJA SL's Logo

CAMPINGCARAVANING PLAYA DE ARIJA SL

Spain

11-50 Employees

-

Ainos is transforming itself into a diversified medtech leader through three innovative business arms: 1. We are committed to a better understanding of low-dose interferon and its applications in strengthening the human body to fight disease or improve innate healing capabilities. Ainos is pushing forward to expand the applications of SRNA. Beginning with improve vaccines, Ainos envisions mRNAs as the future cornerstone of treatments for oncology and acute inflammatory disease. Ainos’s proprietary sensor array technologies effectively gather the complexity of scent data required to make major advances in healthcare AI. Ainos SARS-CoV-2 Antigen Rapid Test Kit is Taiwan's first Covid-19 antigen test co-developed by its national defense, health research institution and a biotech company. The past few years offered deep insight to fundamental gaps in the healthcare industry and an opportunity improve patient outcomes through emerging technologies. We believe our clinical work will improve patient outcomes for various diseases such as Thrombocytopenia and Sjogren’s Syndrome.

Latoxan's Logo

Latoxan

Portes-lès-Valence, France

1-10 Employees

1982

LATOXAN is the leading producer of venoms from snakes, scorpions and batrachians with over 300 different venoms worldwide available. LATOXAN also produces and supplies venom toxins, plant, plant small molecules and screening libraries. LATOXAN supplies Pharmaceutical Industry, Academic and Pharma Research centres and worldwide distributors of Life Science Reagents. Based on a long-standing experience in zoology, LATOXAN is a fully independent company dedicated to the production and sales of high quality venoms and toxins.Founded in 1982, LATOXAN is now a leading supplier in this field, selling to pharmaceutical companies, medical research laboratories and drug discovery units throughout the world.Venoms are produced under strictly controlled conditions from animals we have collected in all parts of the world, or which were born and reared in our breeding facilities.Purified toxins, plant compounds and other similar pharmacological tools are produced in cooperation with leading research institutions. Most molecules provided come with a purity ⪚98%.

Venomtech Ltd's Logo

Venomtech Ltd

Sandwich, United Kingdom

1-10 Employees

2010

We are a global leader for venom research enterprises, based out of world-class laboratories at Discovery Park in Kent, UK. Venomtech, founded by our chief scientific officer, Steve Trim, in 2010, represents the next generation of agile, flexible and innovative smart biotechs. We are committed to helping our customers worldwide make pioneering advances in drug discovery, crop protection and cosmetics. We are passionate about protecting the natural biodiversity across the planet, because the variety of venomous animals throughout nature is the very thing that gives us our success. We are always on the lookout for passionate and innovative prospective employees, so if there are no opportunities advertised, please send us your CV and a covering letter outlining your skills and experience, as well as how you would enhance our Venomtech family. We are a team of enthusiastic problem solvers, with an overall shared goal of developing innovative venom-derived screening tools and lead compounds, to support our customers in achieving their own industry and research goals. Scorpion venom inspires Venomtech to design biomimetic peptide for antiwrinkle cosmetic active. Take a look at who we are, and how our expertise can help you!